Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -1.67 % |
3 Month Return | -7.88 % |
1 Year Return | + 172.15 % |
Market Stats | |
Previous Close | ₹69.29 |
Open | ₹68.00 |
Volume | 40.33K |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹303.41Cr |
P/E Ratio | 0 |
PEG Ratio | 0 |
Market Cap | ₹303.41 Cr |
P/B Ratio | 6.2 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 44.71 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹303.41 Cr | 508.93% | 0.53 | NA | NA | |
NA | ₹472.52 Cr | 99.84% | 0.60 | ₹5 Cr | ₹173 Cr | |
NA | ₹181.61 Cr | 64.87% | 0.56 | NA | NA | |
NA | ₹20.73 Cr | 79.9% | 1.86 | NA | NA | |
NA | ₹221.19 Cr | 63.89% | 0.51 | NA | NA |
Organisation | Shukra Pharmaceuticals Ltd |
Headquarters | |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Shukra Pharmaceuticals Ltd
Shares of Shukra Pharmaceuticals hit a 5% upper circuit and a fresh 52-week high at Rs. 304.25. Despite a revenue decrease, net profits increased by 100%. The stock is undervalued with a PE ratio of 15.5 times compared to the industry average of 33.2 times.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Best in 3 Years
In the last 3 years, Shukra Pharma. has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Best in 1 Year
In the last 1 year, Shukra Pharma. has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Promoter Holding Unchanged
Promoters holdings remained unchanged at 50.96% of holdings in Sep 2024 quarter
Retail Holding Unchanged
Retail Investor holdings remained unchanged at 48.93% of holdings in Sep 2024 quarter
Price Dip
In the last 6 months, Shukra Pharma. stock has moved down by -31.4%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 50.96% | 0.00 | |
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 48.93% | 0.00 | |
Others | 0.11% | 0.00 |
Shukra Pharmaceuticals Ltd’s net profit jumped 16.67% since last year same period to ₹0.49Cr in the Q1 2024-2025. On a quarterly growth basis, Shukra Pharmaceuticals Ltd has generated -87.72% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Shukra Pharmaceuticals Ltd has declared dividend of ₹1 - translating a dividend yield of 2.16%.
Read More about DividendsBearish
Neutral
Bullish
Shukra Pharmaceuticals Ltd is currently in a Bearish trading position according to technical analysis indicators.
Shukra Pharmaceuticals Ltd (524632) share price today is ₹67.99
Shukra Pharmaceuticals Ltd is not listed on NSE
Shukra Pharmaceuticals Ltd is listed on BSE
Today’s traded volume of Shukra Pharmaceuticals Ltd(524632) is 40.33K.
Today’s market capitalisation of Shukra Pharmaceuticals Ltd(524632) is ₹303.41Cr.
Shukra Pharmaceuticals Ltd(524632 | Price |
---|---|
52 Week High | ₹129.9 |
52 Week Low | ₹21.28 |
Shukra Pharmaceuticals Ltd(524632) share price is ₹67.99. It is down -47.66% from its 52 Week High price of ₹129.9
Shukra Pharmaceuticals Ltd(524632) share price is ₹67.99. It is up 219.50% from its 52 Week Low price of ₹21.28
Shukra Pharmaceuticals Ltd(524632 | Returns |
---|---|
1 Day Returns | -1.3% |
1 Month Returns | -1.67% |
3 Month Returns | -7.88% |
1 Year Returns | 172.15% |